The organisation of palliative care

  • G. Linklater
Conference paper


The modern hospice movement was founded in the 1960s as a reaction to an increasingly biomedical model of health care. The focus of medical management, spurred on by rapid advances in diagnostic and therapeutic options, was on treatment and cure. Symptomatic treatments were seen as less important, and death was seen as failure by doctors and a taboo by society as a whole [1].


Palliative Care Cancer Pain Specialist Palliative Care Palliative Medicine Terminal Care 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Doyle D, Hanks GW, MacDonald N (eds) (1998) Oxford textbook of palliative medicine, 2nd edition. Oxford University Press, Oxford, pp 4–8Google Scholar
  2. 2.
    Jenkins V, Fallowfield L, Saul J (2001) Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 84: 48–51PubMedCrossRefGoogle Scholar
  3. 3.
    Addington-Hall J, McCarthy M (1995) Dying from cancer: results of a national population-based investigation. Palliai Med 9: 295–305CrossRefGoogle Scholar
  4. 4.
    Doyle D (1998) The provision of palliative care. In: Doyle D, Hanks GW, MacDonald N (eds) Oxford textbook of palliative medicine, 2nd edition. Oxford University Press, Oxford, pp 41–53Google Scholar
  5. 5.
    World Health Organisation (1990) Cancer pain relief and palliative care. (Technical report series 804 ). WHO, GenevaGoogle Scholar
  6. 6.
    Ventafridda V, Tamburini M, Caraceni A et al (1987) A validation study of the WHO method for cancer pain relief. Cancer 59: 850–856PubMedCrossRefGoogle Scholar
  7. 7.
    Zech DFJ, Grond S, Lynch J et al (1995) Validation of World Health Organisation guidelines for cancer pain relief: a 10-year prospective study. Pain 63: 65–76PubMedCrossRefGoogle Scholar
  8. 8.
    The Expert Working Group of the European Association of Palliative Care (1996) Morphine in cancer pain: methods of administration. BMJ 312: 823–826CrossRefGoogle Scholar
  9. 9.
    Scottish Intercollegiate Guidelines Network and Scottish Cancer Therapy Network (2000) Control of pain in patients with cancer. (SIGN publication number 44 ) Royal College of Physicians, EdinburghGoogle Scholar
  10. 10.
    Hanks GW, de Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84: 587–593PubMedCrossRefGoogle Scholar
  11. 11.
    Meuser T, Pietruck C, Radbruch L et al (2001) Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and aetiology. Pain 93: 247–257PubMedCrossRefGoogle Scholar
  12. 12.
    Hillier R (1988) Palliative medicine. BMJ 297: 874–875PubMedCrossRefGoogle Scholar
  13. 13.
    World Health Organisation (2002) National cancer control programmes, policies and managerial guidelines, 2nd edition. WHO, Geneva pp 83–91Google Scholar
  14. 14.
    Payne S, Sheldon F, Jarrett N et al (2002) Differences in understanding of specialist palliative care amongst service providers and commissioners in South London. Palliat Med 16: 395–402PubMedCrossRefGoogle Scholar
  15. 15.
    Gott CM, Ahmedzai SH, Wood C (2001) How many inpatients at an acute hospital have palliative care needs? Comparing the perspectives of medical and nursing staff. Palliat Med 15: 451–460PubMedCrossRefGoogle Scholar
  16. 16.
    Linklater GT, Leng MEF, Tiernan EJJ et al (2002) Pain management services in palliative care: a national survey. Palliat Med 16: 435–439PubMedCrossRefGoogle Scholar
  17. 17.
    Linklater GT, Leng MEF (2001) Recent advances in pain management in palliative care. Curr Anaesth Crit Care 12: 296–301CrossRefGoogle Scholar
  18. 18.
    Ellershaw J, Ward C (2003) Care of the dying patient: the last hours of life. BMJ 326: 30–34PubMedCrossRefGoogle Scholar
  19. 19.
    World Health Organisation (2003) Global action against cancer. World Health Organisation, GenevaGoogle Scholar
  20. 20.
    Cherny NI, Portenoy RK (1999) Cancer pain: principles of assessment and syndromes. In: Wall PD, Melzack R (eds) Textbook of pain, 4th edition. Churchill Livingstone, Edinburgh, pp 1017–1064Google Scholar
  21. 21.
    Twycross R, Harcourt J, Bergl S (1996) A survey of pain in patients with advanced cancer. J Pain Symptom Manage 12: 273–282PubMedCrossRefGoogle Scholar
  22. 22.
    Addington-Hall J, Fakhoury W, McCarthy M (1998) Specialist palliative care in nonmalignant disease. Palliat Med 12: 417–427PubMedCrossRefGoogle Scholar
  23. 23.
    The SUPPORT principal investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients: The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. JAMA 274: 1591–1598CrossRefGoogle Scholar
  24. 24.
    Zenz M, Willweber-Strumpf A (1993) Opioidphobia and cancer pain in Europe. Lancet 341: 1075–1076PubMedCrossRefGoogle Scholar
  25. 25.
    World Health Organisation (2000) Narcotics and psychotropic drugs. Achieving balance in national opioids control policy. Guidelines for assessment. WHO, GenevaGoogle Scholar
  26. 26.
    Reidenberg MM (1996) Barriers to controlling pain in patients with cancer. Lancet 347: 1278PubMedCrossRefGoogle Scholar
  27. 27.
    UN International Narcotics Control Board (1995) Report: Availability of opiates for medical needs. International Narcotics Control Board, United Nations, ViennaGoogle Scholar
  28. 28.
    Wall PD (1997) The generation of yet another myth on the use of narcotics. Pain 73: 121–122PubMedCrossRefGoogle Scholar
  29. 29.
    Joranson DE, Ryan KM, Gilson AM et al (2000) Trends in medical use and abuse of opioid analgesics. JAMA 283: 1710–1714PubMedCrossRefGoogle Scholar
  30. 30.
    Zhukovsky DS, Gorowski E, Hausdorff J et al (1995) Unmet analgesic needs in cancer patients. J Pain Symptom Manage 10: 113–119Google Scholar
  31. 31.
    Twycross R, Willcock A, Charlesworth S et al (2002) Palliative care formulary, 2nd edition. Radcliffe Medical Press, Oxon, pp 168–175Google Scholar
  32. 32.
    Hanks GW, Twycross RG, Lloyd JW (1981) Unexpected complication of successful nerve block. Anaesthesia 36: 37–39PubMedCrossRefGoogle Scholar
  33. 33.
    Borgbjerg FM, Nielsen K, Franks J (1996) Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain 64: 123–128PubMedCrossRefGoogle Scholar
  34. 34.
    McQuay H (1999) Opioids in pain management. Lancet 353: 2229–2232PubMedCrossRefGoogle Scholar
  35. 35.
    Collin E, Poulain P, Gauvain-Piquard A et al (1993) Is disease progression the major factor in morphine `tolerance’ in cancer pain treatment? Pain 55: 319–326PubMedCrossRefGoogle Scholar
  36. 36.
    Twycross R (1997) Symptom management in advanced cancer, 2nd edition. Radcliffe Medical Press, Oxford, pp 86–91Google Scholar
  37. 37.
    Welsh J, Brewster D, Cornbleet M et al (2001) A Scottish national audit of prevalence of pain in patients with active cancer. Poster presented the Seventh Congress of the European Association of Palliative CareGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2004

Authors and Affiliations

  • G. Linklater

There are no affiliations available

Personalised recommendations